INNOVEX THERAPEUTICS S.L.  is the first Spanish company devoted to the valorization of Exosomes and Extracellular Vesicles as new platforms for vaccines and/or diagnostic tools. Cornerstone of the Spin-off is the discovery that reticulocyte-derived exosomes (rex) from malaria infections could be used as a new platform and vaccine against this disease. This approach is internationally protected  (PCT/EP2010/070800).

INNOVEX THERAPEUTICS S.L. is a brand new Spin-off co-founded by Hernando A del Portillo and Francesc E. Borrás, with 10% accionary participation of three Research Institutions:

icrea  Institució Catalana de Recerca i Estudis Avançats

igtp  Institut for Biomedical Research “Germans Trias i Pujol”

cresib  The Barcelona Centre for International Health Research




Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s